Size: px
Start display at page:

Download ""

Transcription

1

2

3 gtf Wnt5a-Ror2 IL-8 in vitro

4 Ozony Tron P. gingivalis SOD ELISA Location of main occluding areas and masticatory ability in patients with reduced occlusal support

5 12-Methacryloyloxydodecylpyridinium bromide MDPB MDPB PB PB EPMA Streptococcus mutans PB WPB WPB WPB EPMA WPB PB FS WPB PB FS

6 Streptococcus mutans nm WPB MDPB MDPB WPB EPMA WPB Streptococcus mutans WPB

7 Poly P Poly P Ca Poly P Poly P MC3T3-E 1 ALP p-nitrophenyl phosphate substrate, ph10.5 Fluoresceinisothiocyanate FITC annexin V propidium iodide PI flow cytometory FCM total RNA reverse transcriptase-polymerase chain reaction RT-PCR Poly P polyethyleneimine thin layer chromatography PEI-TLC plate MC3T3-E1 Poly P Pi mmol/l MC3T3-E1 mmol/l Poly P ALP MC3T3-E1 mmol/l Poly P FCM Poly P

8 PI annexin V Poly P MC3T3-E1 osteocalcin β- Poly P MC3T3-E1 Poly P PEI-TLC Poly P Poly PPi PPi Pi3 Pi4 MC3T3-E1 β- Poly P Poly P Emdogain p Poly P Poly P Poly P Poly P Poly P Poly P Pi PPi Pi3 Poly P in vivo Poly P Poly P Poly P Poly P MC3T3-E1 in vivo in vitro

9

10 gtf CSI dft CSI dftcsi Real-time PCR S. mutans S.sobrinus gtf gtf gtf B gtf C gtf D

11 gtf I S. mutans gtf B D gtf B D S. sobrinus S. mutans gtf I gtf S. mutans S. sobrinus gtf B gtf C gtf D dft CSI dftcsi Real-time PCR S. mutans S. sobrinus S. mutans gtf B gtf D gtf

12

13 Wnt5a-Ror2 TNFα IL-1 Wnt5a Wnt5a Ror2 Wnt5a RT-PCR D Wnt5a GST-soluble Ror2 GST-sRor2 GST Ror2 Wnt5a Mφ M-CSF RANKL TRAP HE Ror2 Wnt5a GST-sRor2

14 GST Wnt5a Ror2 Mφ Wnt5a Mφ M-CSF RANKL Mφ Wnt5a Ror2 Wnt5a Wnt5a Wnt5a-Ror2 Wnt 5a Ror2 GST-sRor2 GST-sRor2 Wnt Wnt5a Ror2 Wnt5a Ror2 Wnt5a Ror2 RT-PCR Wnt5a Ror2 Ror Ror2 GST-sRor2Wnt5a Wnt5a Ror2 Wn5a-Ror2 Ror2 Wnt5a-Ror2 Wnt

15 Wnt5a Ror2 Ror2 Wnt5a Wnt5a-Ror2

16 IL-8 AZM in vitro AZM IL -8 IL-8 TNF-α AZM AZM in vitro MMP EM AZM JOM Porphyromonas gingivalis LPS ng/ml IL-6 IL-8 PGE ELISA µg/ml IL-6 IL-8 PGE MMP

17 AMZ LPS IL-8 EM JOM LPS IL-8 LPS IL-6 PGE MMP-2 MMP-9 AZM LPS IL-8 ERK JNK p38mapk PKA PI3K PLCγ NF-κB IL-8 NF-κB PGE AZM LPS IL-8 in vitro PGEIL-6 IL-8 AZM LPS IL-8 AZM IL-8 IL-8 IL-6 IL-8 PGE

18 1.8-cineol 1.8-cineol 1.8-cineol mg/ml Candida albicans JCM 1842 Klebsiella pneumoniae JCM 1662 Prevotella intermedia ATCC Prevotella nigrescens ATCC Actinobacillus actinomycetemcomitans JCM 8577 Porphyromonas gingivalis ATCC Streptococcus mutans Ingbritt Streptococcus sobrinus 6715 Streptococcus salivarius JCM cineol 1.8-cineol Streptococcus salivarius

19 1.8-cineol 1.8-cineol 1.8-cineol

20

21 µm

22 R SS SEP g SEP P N P -N µ P -N P -N

23 SEP SEP SEP

24 AIC χ Fisher s exact probability test

25

26 cdna PCR in situ ISH real time PCR myelin basic protein MBP MBP

27 ISH MBP MBP real time PCR myelin basic protein MBP PCR real time PCR in situ

28 in vitro PG EIL-6 IL-8 in vitro Porphyromonas gingivalis LPS ng/ml PGEIL-6 IL-8 ELISA MEK DMSO LPS COX -2 - mg/ml COX COX Inhibitor Screening Assay Kit COX Inhibitor Screening Assay Kit AcPLA ERK ERK LPS COX R http : //

29 LPS PGE LPS PGE LPS IL-6 IL-8 COX-1 COX-2 LPS COX-2 mg/ml LPS cpla ERK cpla MEK LPS PGE MEK LPS IL-6 IL-8 LPS PGE LPS PGE ERK ERK cpla PGE LPS in vitro PGEIL-6 IL-8 ERK cplapge in vitro

30

31 -L-

32 VF VE QOL VE VE VE VF

33 Wallenberg VF

34 BMP in vitro in vivo

35

36 R SS SEP A SEP P - N A A

37 P -N A P -N P -N P -N P -N A P -N P -N A A SEP A

38 A A

39 A Ca bfgf bfgf in vitro Gin-1-1 WST-1 Gin-1 / µm DMSO bfgf ELISA Gin-1 mm bfgf Student t p

40 Gin-1 bfgf in vitro in vitro Gin-1

41 Candida albicans C. albicans JCM1542 MCZ NCCLS MCZ MIC80 MCZ RPMI µg/ml MCZ µl GC mmφmm stroke / CFU/ml C. albicans µl SCDLP C. albicans µg/ml MCZ MCZ MIC -µg/ml RPMI µg/ml

42 MIC MCZ C. albicans µg/ml µg/ml - MCZ MCZ

43 Ozony Tron Ozony Tron Ozony Tron

44 Ozony Tron Ozony Tron

45 P. gingivalis SOD ELISA SOD Porphyromonas gingivalis P. g. SOD SOD Fe-SODMn -SOD P. g. SOD Amano, A J Bacteriol 172 : , 1990 P. gingivalis Fe-SOD Mn-SOD P. g. SOD P. g. SOD ELISA ELISA SOD SOD SOD microtiter plate ELISA P. gingivalis ATCC SOD ELISA SOD

46 pmolnmol P. g. SOD ELISA SOD SOD SOD SOD SOD ELISA SOD P. g. SOD ELISA P. g. SOD ELISA ELISA P. g. SOD pmolnmol P. g. SOD ELISA ELAISA P. gingivalis SOD SOD SOD ELISA SOD P. gingivalis P. g. SOD ELISA SOD P. gingivalis SOD P. gingivalis P. g. SOD ELISA SOD

47 Cambialistic SOD Fe Mn SOD P. g. SOD P. gingivalis P. gingivalis SOD

48 Location of main occluding areas and masticatory ability in patients with reduced occlusal support Eichner A1 Eichner B1 B4 C1 C3 mm PM M Eichner

49 Eichner A1 Eichner B C Eichner C1 Eichner Chi square test ; p Eichner A1 B1 C3 Eichner one-factor ANOVA ; p PM M Student t-test ; p Eichner

日歯雑誌(H28・8月号)別刷り/ポスターセッション とびら

日歯雑誌(H28・8月号)別刷り/ポスターセッション とびら α P. gingivalis P. gingivalis αsmatgf- VEGF-A α in vitro μ Porphyromonas gingivalis in vitro Porphyromonas gingivalis β β β JBiolChem. μ μ μ β Porphyromonas gingivalis in vitro μ α β α

More information

µ µ µ µ

µ µ µ µ Title 東 京 歯 科 大 学 研 究 年 報 : 平 成 15 年 度 Journal 東 京 歯 科 大 学 研 究 年 報, (): - URL http://hdl.handle.net/10130/388 Right Posted at the Institutional Resources for Unique Colle Available from http://ir.tdc.ac.jp/

More information

nsg02-13/ky045059301600033210

nsg02-13/ky045059301600033210 φ φ φ φ κ κ α α μ μ α α μ χ et al Neurosci. Res. Trpv J Physiol μ μ α α α β in vivo β β β β β β β β in vitro β γ μ δ μδ δ δ α θ α θ α In Biomechanics at Micro- and Nanoscale Levels, Volume I W W v W

More information

untitled

untitled ver. 3.3JT EVENING PRIMROSE EXTRACT 1 - PMS 1 2 1 4 Oenothera laciniata Oenothera striata Oenothera biennis Oenothera erythrosepala - 2 80 60 40 20 0 1. 2 3 PGGPAC 2. 3 4 ESR3.5 10 5 /g 4 3 1 Helicobacter

More information

第86回日本感染症学会総会学術集会後抄録(I)

第86回日本感染症学会総会学術集会後抄録(I) κ κ κ κ κ κ μ μ β β β γ α α β β γ α β α α α γ α β β γ μ β β μ μ α ββ β β β β β β β β β β β β β β β β β β γ β μ μ μ μμ μ μ μ μ β β μ μ μ μ μ μ μ μ μ μ μ μ μ μ β

More information

研修コーナー

研修コーナー l l l l l l l l l l l α α β l µ l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l

More information

Newsletter for JADR 2

Newsletter for JADR 2 Japanese Association for Dental Research 2004-2 September Newsletter for JADR 1 Newsletter for JADR 2 Newsletter for JADR Newsletter for JADR Newsletter for JADR Newsletter for JADR q w Streptococcus mutans

More information

プログラム

プログラム 12 Porphyromonas gingivalis Porphyromonas gingivalis Porphyromonas gingivalis Porphyromonas gingivalis Porphyromonas gingivalis Porphyromonas gingivalis 13 14 Porphyromonas gingivalis fima fi ma Porphyromonas

More information

untitled

untitled er. 3.0SJ ver.3.0 SJ 3 2 1 ver.3.0 SJ 900 1200 () 400 2 ver.3.0 SJ OH OMe OMe O O O MeO O MeO OMe O O OMe O OMe OMe O O MeO O O H O O MeO OMe O H O OH OMe O CH 2 HO O O O O CH 3 OH HO OH OH HO OH O 1 3

More information

nsg04-28/ky208684356100043077

nsg04-28/ky208684356100043077 δ!!! μ μ μ γ UBE3A Ube3a Ube3a δ !!!! α α α α α α α α α α μ μ α β α β β !!!!!!!! μ! Suncus murinus μ Ω! π μ Ω in vivo! μ μ μ!!! ! in situ! in vivo δ δ !!!!!!!!!! ! in vivo Orexin-Arch Orexin-Arch !!

More information

untitled

untitled CH 2 H H H CH 2 n-1 H CH 2 n H Potato α-glucan phosphorylase H n soluble starch P i n-1 H P() 2 glucose-1-phosphate Pi H CBPase H glucose P i glucose-1-phospate cellobiose H cellooligosaccharide n+1 CDPase

More information

50mg 75mg (1) H 3 C O OH HO H O O H OH SO H 3 Na H H N H 2 N NH OH H N O O H H O OH H 3 C H O O N H H H HO H NH CH 3 HN HO H OH O H OH H NH

50mg 75mg (1) H 3 C O OH HO H O O H OH SO H 3 Na H H N H 2 N NH OH H N O O H H O OH H 3 C H O O N H H H HO H NH CH 3 HN HO H OH O H OH H NH 3240 14 8 8 50mg 75mg 13 6 25 1-(1) H 3 C O OH HO H O O H OH SO H 3 Na H H N H 2 N NH OH H N O O H H O OH H 3 C H O O N H H H HO H NH CH 3 HN HO H OH O H OH H NH O N O C 56 H 70 N 9 NaO 23 S 1292.26 5-[(1S,2S)-2-

More information

1 911 9001030 9:00 A B C D E F G H I J K L M 1A0900 1B0900 1C0900 1D0900 1E0900 1F0900 1G0900 1H0900 1I0900 1J0900 1K0900 1L0900 1M0900 9:15 1A0915 1B0915 1C0915 1D0915 1E0915 1F0915 1G0915 1H0915 1I0915

More information

O1-1 O1-2 O1-3 O1-4 O1-5 O1-6

O1-1 O1-2 O1-3 O1-4 O1-5 O1-6 O1-1 O1-2 O1-3 O1-4 O1-5 O1-6 O1-7 O1-8 O1-9 O1-10 O1-11 O1-12 O1-13 O1-14 O1-15 O1-16 O1-17 O1-18 O1-19 O1-20 O1-21 O1-22 O1-23 O1-24 O1-25 O1-26 O1-27 O1-28 O1-29 O1-30 O1-31 O1-32 O1-33 O1-34 O1-35

More information

日本医科大学医学会雑誌第8巻第1号

日本医科大学医学会雑誌第8巻第1号 Xenopus laevis in situ μ μ Xenopus laevis Xenopus laevis Xenopus laevis UGT1A1 UGT1A1 IL28B KRAS UGT1A1 UGT1A128 UGT UGT1A1 UGT1A128 UGT1A1 286 UGT1A1 UGT1A1 28 6 UGT UGT UGT1A128 UGT IL28B UGT1A1

More information

< B C957491E48E86312E696E6464>

< B C957491E48E86312E696E6464> 10 DDS New York Academy Renal Biochemistry (Elsevier) Glutathione (John Wiley & Sons) Antioxidants in Therapy and Preventive Medicine (Plenum) The Liver: Biology and Pathophysiology (Raven Press) NO SSC

More information

1. 1) (1) in vitro i ii in vitro ex vivo (2) (3) ET i BALF ii CVF i ii BALF i ii iii BALF i ii ET 2) (1) in vitro (2) in vitro (3) in vitro (4)

1. 1) (1) in vitro i ii in vitro ex vivo (2) (3) ET i BALF ii CVF i ii BALF i ii iii BALF i ii ET 2) (1) in vitro (2) in vitro (3) in vitro (4) 1. 1) (1) in vitro i ii in vitro ex vivo (2) (3) ET ibalf ii CVF i iibalf i ii iiibalf i ii ET 2) (1) in vitro (2) in vitro (3) in vitro (4) ET CVF (5) (6) 3) (1)in vitro 2. 1)ONO-5046Na (1) (2) (3) (4)

More information

N cos s s cos ψ e e e e 3 3 e e 3 e 3 e

N cos s s cos ψ e e e e 3 3 e e 3 e 3 e 3 3 5 5 5 3 3 7 5 33 5 33 9 5 8 > e > f U f U u u > u ue u e u ue u ue u e u e u u e u u e u N cos s s cos ψ e e e e 3 3 e e 3 e 3 e 3 > A A > A E A f A A f A [ ] f A A e > > A e[ ] > f A E A < < f ; >

More information

- 1 -

- 1 - - 1 - - 1 - ... 1... 2... 4... 5... 9... 11... 14... 16... 20... 21... 22... 23... 23 - 1 - - 2 - - 3 - - 4 - - 5 - - 6 - - 7 - - 8 - - 9 - ( ) - 10 - - 11 - Pseudomonas aeruginosa Escherichia coli Staphylococcus

More information

08-g-”O−}„j‹ê-4.02

08-g-”O−}„j‹ê-4.02 200( 96 ) THE JAPANESE JOURNAL OF ANTIBIOTICS 58 2 Apr. 585 1 17 MIC 1. (Transtracheal aspiration: TTA) TTA TTA TTA 1400 TTA (diffuse panbronchiolitis, DPB) 1) erythromycin(em) EM 12.5% 87.5% 2,3) EM EM

More information

n 2 + π2 6 x [10 n x] x = lim n 10 n n 10 k x 1.1. a 1, a 2,, a n, (a n ) n=1 {a n } n=1 1.2 ( ). {a n } n=1 Q ε > 0 N N m, n N a m

n 2 + π2 6 x [10 n x] x = lim n 10 n n 10 k x 1.1. a 1, a 2,, a n, (a n ) n=1 {a n } n=1 1.2 ( ). {a n } n=1 Q ε > 0 N N m, n N a m 1 1 1 + 1 4 + + 1 n 2 + π2 6 x [10 n x] x = lim n 10 n n 10 k x 1.1. a 1, a 2,, a n, (a n ) n=1 {a n } n=1 1.2 ( ). {a n } n=1 Q ε > 0 N N m, n N a m a n < ε 1 1. ε = 10 1 N m, n N a m a n < ε = 10 1 N

More information

›Ê”÷„¤‰ƒ‘−…j…–†[…X

›Ê”÷„¤‰ƒ‘−…j…–†[…X ISSN 1347-0345 National Institute of Fruit Tree Science 2003. 10 2 2003. 10 3 19761986 1989 5219 1997 19 12 10 250 270g Brix 15 160.5g/100ml 1590 10 2003. 10 4 DNA DNASSR 44 41SSR SSR Simple Sequence Repeat=

More information

日本歯科保存学会2011年度春季学術大会(134回)

日本歯科保存学会2011年度春季学術大会(134回) ii 2011 134 Program and Abstracts, the 134th Meeting of the Japanese Society of Conservative Dentistry, June 910, 2011, Chiba A 1F B 1F 2 1F 6 9 A112 B112 P160 6 10 A1319 B1319 P61114 A2028 B2028 6 910

More information

untitled

untitled 20 2 14 18 10 16 1 1.0mg 0.035mg 2 1 20 2 14 18 10 16 1 1 1 52 1 1 21 7 28 1 29 2 1 20 1 24 18 10 16 1 1 21 7 28 1 29 1 NET 1.0mg EE 0.035mg *NET *NET 1999 2007 *NET *NET 88 NSAIDs GnRH GnRH NSAIDs 20

More information

第14〜15回 T細胞を介する免疫系.pptx

第14〜15回 T細胞を介する免疫系.pptx MBL CD8 CD4 8.1 8.2 5.20 8.3 8.4 8.5 8.6 8.7 8.8 8.9 8.10 8.18 B7 CD28 CD28 B7 CD28 8.13 2.22 NK Toll(TLR) LBP! LPS dsrna ssrna TLR1/2/6! TLR4 TLR5 TLR3 TLR7/9 CD14! JNK/p38! MyD88! IRAK! TRAF! NFκB! TNF-α

More information

ver5.1 HS 1. ALPHA LIPOIC ACID () S S COOH HS 1. α - SH COOH - ( 1) CoA -( 2)- - --P80 (--WSP8-L1-WSPC8 -LC1) - 1

ver5.1 HS 1. ALPHA LIPOIC ACID () S S COOH HS 1. α - SH COOH - ( 1) CoA -( 2)- - --P80 (--WSP8-L1-WSPC8 -LC1) - 1 ORYZA OIL & FAT CHEMICAL CO., LTD. ALPHA LIPOIC ACID --P () --P80 () --WSP8 () --L1 () --PC () --PC80 () --WSPC8 () --LC1 () ver. 5.1HS ver5.1 HS 1. ALPHA LIPOIC ACID 16 3 31 0331009 - () 19 5 24 0524001

More information

.r.[...X.j...[.X5..-.{..4C

.r.[...X.j...[.X5..-.{..4C Hiroshima University Graduate School of Biomedical Sciences Streptococcus mutanss. sobrinus S. mutanss. mutanss. sobrinuss. sanguinis S. salivariuss. mitis in vivo S. mutanss. sobrinus S.mutans

More information

AS LMD Sampling Manual

AS LMD Sampling Manual AS LMD Application Solutions LaserMicrodissection System LMD SamplingManual 2005 1 AS LMD Sampling Manual -------------------------------------------------------------2 --------------------------------------

More information

τ τ

τ τ 1 1 1.1 1.1.1 τ τ 2 1 1.1.2 1.1 1.1 µ ν M φ ν end ξ µ ν end ψ ψ = µ + ν end φ ν = 1 2 (µφ + ν end) ξ = ν (µ + ν end ) + 1 1.1 3 6.18 a b 1.2 a b 1.1.3 1.1.3.1 f R{A f } A f 1 B R{AB f 1 } COOH A OH B 1.3

More information

Microsoft Word - H18年度生命工学報告書 Astro ver.3

Microsoft Word - H18年度生命工学報告書 Astro ver.3 1. Rotavirus Norovirus Adenovirus Astrovirus Sapovirus 5 1) Human Astrovirus HastV 1975 Madeley Cosgrove EM RNA 30nm 5 6 Fig. 1 2) HastV 8 3 5 HastV ELISA Enzyme-Linked ImmunoSorbent Assay RIA Radio immunoassay

More information

日本化学療法学会雑誌第58巻第2号

日本化学療法学会雑誌第58巻第2号 Key words β Candida Table1. MCFGCPAstudygroup Investigator (representative) YoshitsuguMiyazaki NaoyukiMiyashita RyoichiAmitani KenjiOgawa AtsuyukiKurashima ToshiroKiguchi MichiakiMishima YuichiInoue HiroshiSaito

More information

研究目的 1. 電波ばく露による免疫細胞への影響に関する研究 我々の体には 恒常性を保つために 生体内に侵入した異物を生体外に排除する 免疫と呼ばれる防御システムが存在する 免疫力の低下は感染を引き起こしやすくなり 健康を損ないやすくなる そこで 2 10W/kgのSARで電波ばく露を行い 免疫細胞

研究目的 1. 電波ばく露による免疫細胞への影響に関する研究 我々の体には 恒常性を保つために 生体内に侵入した異物を生体外に排除する 免疫と呼ばれる防御システムが存在する 免疫力の低下は感染を引き起こしやすくなり 健康を損ないやすくなる そこで 2 10W/kgのSARで電波ばく露を行い 免疫細胞 資料 - 生電 6-3 免疫細胞及び神経膠細胞を対象としたマイクロ波照射影響に関する実験評価 京都大学首都大学東京 宮越順二 成田英二郎 櫻井智徳多氣昌生 鈴木敏久 日 : 平成 23 年 7 月 22 日 ( 金 ) 場所 : 総務省第 1 特別会議室 研究目的 1. 電波ばく露による免疫細胞への影響に関する研究 我々の体には 恒常性を保つために 生体内に侵入した異物を生体外に排除する 免疫と呼ばれる防御システムが存在する

More information

「東京都子供・子育て支援総合計画」中間見直し版(案)第2章 子供と家庭をめぐる状況

「東京都子供・子育て支援総合計画」中間見直し版(案)第2章 子供と家庭をめぐる状況 1 (1) (2) (3) (4) (5) (6) (7) (8) 2 (1) (2) (3) (4) (5) (6) (7) 10,000 100% 8,000 78.7% 78.1% 79.3% 78.3% 74.1% 75.4% 73.2% 80% 6,000 46.6% 47.5% 50.9% 51.5% 49.9% 51.8% 52.2% 60% 4,000 2,000 3,713

More information

JP.qxd

JP.qxd Agilent 2100 1 DNA RNA Lab-on-a-Chip Agilent 2100 1999 Agilent 2100 Lab-on-a-Chip Agilent 2100 RNA DNA SDS-PAGE Agilent 2100 Agilent 2100 Agilent 2100 : (1 4 µl) 30 21 CFR Part 11 Agilent 2100 Agilent

More information

- 2 -

- 2 - - 1 - RI Martin D. Kamen P450 MD Kamen Vanderbilt Howard Gest Indiana 32 P J. Biol. Chem., 1948 15N - 2 - - 3 - ATP ATP-DnaA/oriC DnaB DnaC DnaG DNA III B (pol III* + β ) G B G pol III* β - 4 - β Hda A

More information

2.7 臨床概要

2.7 臨床概要 2.7 臨床概要 A/G Al-P ALT AST AT- AUC AZM BIPM BP BUN CEZ CFPN-PI CFU CLcr Cmax CNS COPD CPFX CRP CS CYP CVA DBT DHP-I DIC DRPM DRPM-DC FAS γ-gtp GCP GNB GNF-GNR GPB HAM - Staphylococcus C P450 -I Full Analysis

More information

日本化学療法学会雑誌第54巻第S-1号

日本化学療法学会雑誌第54巻第S-1号 β β Key words β Candida krusei Candida glabrata β I β Drugadministration Baselinecharacteristics Clinicalsymptom Mycologicaltests Plasmadrugconcn Adverseevents Laboratorytests ) -leadecg Clinicalphotograph

More information

能書単頁9[1].5(2)

能書単頁9[1].5(2) ips CytoTune -ips ver.1.0 1 I CytoTune ips 3 II 3 3 4 5 III CytoTune ips ips 6 6 6 6 7 1) 2) ips 8 ips 8 SeV 9 SeV 10 IV Q&A 11 V 12 12 VI...13 13...13 2 I CytoTune ips CytoTune ips 4 OCT3/4SOX2 KLF4c

More information

日本化学療法学会雑誌第56巻第1号

日本化学療法学会雑誌第56巻第1号 β β β β β Streptococcus pneumoniaehaemophilus influenzaemoraxella catarrhalismycoplasma pneumoniaechlamydia pneumoniae β Key wordsβ mys nilc laci ngis Table. Assessmentschedule Parameters Patientcharacteristics

More information

「スウェーデン企業におけるワーク・ライフ・バランス調査 」報告書

「スウェーデン企業におけるワーク・ライフ・バランス調査 」報告書 1 2004 12 2005 4 5 100 25 3 1 76 2 Demoskop 2 2004 11 24 30 7 2 10 1 2005 1 31 2 4 5 2 3-1-1 3-1-1 Micromediabanken 2005 1 507 1000 55.0 2 77 50 50 /CEO 36.3 37.4 18.1 3-2-1 43.0 34.4 / 17.6 3-2-2 78 79.4

More information

1.8.2 Page MIC () MIC 50 / MIC 90 µg/ml Candida albicans (54) / Candida glabrata (25) 0.25 / 0.5 Candida guilliermondii a) (2)

1.8.2 Page MIC () MIC 50 / MIC 90 µg/ml Candida albicans (54) / Candida glabrata (25) 0.25 / 0.5 Candida guilliermondii a) (2) 1.8.2 Page1 1.8.2 96% 2002 40 B 1 123 (1) in vitro 1) in vitro C. glabrata C. krusei 1 2 19951997 3 1999 2002 MIC MIC 2 1.8.2 Page2 1 19951997 MIC () MIC 50 / MIC 90 µg/ml Candida albicans (54) 0.016 /

More information

取扱説明書 [F-05E]

取扱説明書 [F-05E] F-05E 12.11 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 a b 22 c d e 23 24 a o c d a b p q b o r s e f h i j k l m g f n a b c d e f g h 25 i j k l m n o p q r s a X b SD 26 27 28 X 29 a b c

More information

スライド 1

スライド 1 平成 29 年 6 月 1 日研究成果発表 広島大学大学院 医歯薬保健学研究院 二川浩樹 虫歯 歯周病を抑える L8020 乳酸菌を利用 産学連携で新しいタブレットが誕生 2010 年 10 月 歯磨きしなくても虫歯にならない 昭和 47 年 6 月 29 日生まれ 30 歳 女性 FJ 病院 むし歯の治療歴のない FJ さん 昭和 47 年 6 月 29 日生まれ,30 歳, 女性の口腔内写真 必ずしも口腔内衛生状態は良いわけではない

More information

Microsoft Word - web.docx

Microsoft Word - web.docx 12 10 E 16:30 17:30 : ( ) " " ( ) 12 10 15:50 16:20 A 1 ( ) ( ) B ( ) ( ) D ( ) ( 12 11 B 10:00 12:00 " " ( ) ( ) 2 (10 ) A 1 ( ) 8:30 12:40 8:30 9:20 1 ( ) 1A-01 Cannabidiol-2',6'-dimethyl ether ( 1,

More information

MUFFIN3

MUFFIN3 MUFFIN - MUltiFarious FIeld simulator for Non-equilibrium system - ( ) MUFFIN WG3 - - JCII, - ( ) - ( ) - ( ) - (JSR) - - MUFFIN sec -3 msec -6 sec GOURMET SUSHI MUFFIN -9 nsec PASTA -1 psec -15 fsec COGNAC

More information

2009 SEP. No.664 9 18 100460345 209710798 %0.11 3350955 9750799 12.1 0.93 100350 19 100600453 209700800 %0.03 3200065 9740873 11.0 0.98 90490 20 100750364 209680396 %0.81 321 844 978 591 11.6

More information

untitled

untitled PCRM-PCR PCR MPCR Dualreal PCR PCR (M-PCR) PCR (M-PCR) Q & A PCR DNA 50 2030 DNA PCR 1 PCR (MPCR) MBI PCR 1 MPCR 1 MPCR DNA 1 PCR 510 DNA (US patent 5, 582, 989) 1 DNA ( 1) MPCR GC MBI MPCR PCR DNA 2 MBI

More information

Aqua Way Philic Aqua Way Cation Technology platform Cell-sheet engineering (1) Technology platform Cell-sheet engineering (2) 1) Collection of cells in a form of thin film 2) o suture required for transplantation

More information

ROWCatPathology_J.book

ROWCatPathology_J.book www.dako.jp IHC Solution Visualization Systems Number of Steps 5 4 3 2 1 LSAB TM 2 EnVision TM G 2 Doublestain EnVision TM DuoFLEX Doublestain LSAB TM + EnVision TM G 2 EnVision TM + EnVision TM FLEX 1

More information

Donald Carl J. Choi, β ( )

Donald Carl J. Choi, β ( ) :: α β γ 200612296 20 10 17 1 3 2 α 3 2.1................................... 3 2.2................................... 4 2.3....................................... 6 2.4.......................................

More information

明海大学歯学雑誌 44‐2☆/学術大会抄録(44‐2)26

明海大学歯学雑誌 44‐2☆/学術大会抄録(44‐2)26 26 S23 26 2015 6 4 9 :00 1 2 QOL Fujifilm 3 Fujifilm 13 W 7 D 10 H cm FinePix REAL 3D w3m, Fujifilm 3D, Armonicos Epipolar RGB Correction using Color Information, CCI BRGBmax RGBmin2 Y 0.299 R 0.587 G

More information

研究成果報告書(基金分)

研究成果報告書(基金分) DNA cdna mrna DNA ( /) (PS) (PS-tag: RIIIRRIRR) PS scfv PS-tag PS-tag scfv (PMMA)(PC) -S- (GST)PC PMMA GST GST PMMA-tag: DVEGIGDVDLVNYFEVGAT- YTFNK PC-tag: NSNFFGLVDGLNF- AVQYLGK) -S- PS-tag PMMA-tagPC-tag

More information

参考資料5 農薬評価書 メタアルデヒド(食品安全委員会資料)

参考資料5 農薬評価書 メタアルデヒド(食品安全委員会資料) 1 3 3 4 5. 6 1. 6 2. 6 3. 6 4. 6 5. 6 6. 6 7. 6. 7 1. 7 2. 8 (1) 8 (2) 9 (3) 9 (4) 10 (5) 10 3. 11 (1) 11 (2) 11 (3) 11 (4) 12 4. 12 (1) 12 (2) 12 (3) 13 5. 13 6. 13 7. 14 8. 15 9. 16 10. 16 (1) 90 16-1

More information

ッ ー ー ー() () 2.5 () () 21 1) -1 2) -2 10 m 5 7 23 6 1)2) 3) -1-2 H23.4.25 -15-20 4 75 5 1) -1 (5) (3) (3) (2) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) 1) ( 23 6 8 ) 2) 22 3)

More information

(2009) 1... / 1 ( ) / 1 ( ) / 1 ( ), 2 ( )

(2009) 1... / 1 ( ) / 1 ( ) / 1 ( ), 2 ( ) 212009................................................ 2............................................ 115 (2009) 1... / 1 ( )........................................... 4 2... / 1 ( )......................................

More information

1.500 m X Y m m m m m m m m m m m m N/ N/ ( ) qa N/ N/ 2 2

1.500 m X Y m m m m m m m m m m m m N/ N/ ( ) qa N/ N/ 2 2 1.500 m X Y 0.200 m 0.200 m 0.200 m 0.200 m 0.200 m 0.000 m 1.200 m m 0.150 m 0.150 m m m 2 24.5 N/ 3 18.0 N/ 3 30.0 0.60 ( ) qa 50.79 N/ 2 0.0 N/ 2 20.000 20.000 15.000 15.000 X(m) Y(m) (kn/m 2 ) 10.000

More information

1.2 M N M d- BBB / ChE etc ChE etc CCh BCh etc Ach ChE 2 Ach ChE PAM ChE

1.2 M N M d- BBB / ChE etc ChE etc CCh BCh etc Ach ChE 2 Ach ChE PAM ChE 1 - d- etc etc d-tc ChE > < < < > > > or 1.1 1 d- < dtc Na + Na + I II ChE ChE ChE ( ) T Ca++ 1 Na + K + Na + Ach Ach Ach BTX Mg 2+ Ach CAT TTX Ach 1.2 M N M d- BBB / ChE etc ChE etc CCh BCh etc Ach ChE

More information

untitled

untitled PCR Enzymes & Instruments PCR Stratagene Gradient Cycler Problem PCRDNA Polymerase Solution Stratagene Gradient Cycler PCRQuikChange 3 Stratagene Gradient Cycler 96 96 Fast 384 3 3 0.4 0.1 12 96 Fast 384

More information

3 1 2

3 1 2 Agilent 4200 TapeStation Agilent 4200 TapeStation 3 1 2 2 3 ScreenTape 3 Agilent 4200 TapeStation QC Agilent 4200 TapeStation Ready-to-use ScreenTape 8 PCR 96-well plate 1 96 1 qrt-pcr DNA RNA DNA / RNA

More information

2006/11/18 02:29 PM file:///users/ks/website/lazyjack2006/html/products/kumi/tmp29czi8xk8o.htm

2006/11/18 02:29 PM file:///users/ks/website/lazyjack2006/html/products/kumi/tmp29czi8xk8o.htm LazyJack[ ] 2006/11/18 03:52 PM file:///users/ks/desktop/kumi/1hajime.html 2006/11/18 02:29 PM file:///users/ks/website/lazyjack2006/html/products/kumi/tmp29czi8xk8o.htm 2006/11/18 02:30 PM file:///users/ks/website/lazyjack2006/html/products/kumi/tmp2b4ao8xkay.htm

More information

PowerPoint プレゼンテーション

PowerPoint プレゼンテーション 0 1 2 3 4 5 6 1964 1978 7 0.0015+0.013 8 1 π 2 2 2 1 2 2 ( r 1 + r3 ) + π ( r2 + r3 ) 2 = +1,2100 9 10 11 1.9m 3 0.64m 3 12 13 14 15 16 17 () 0.095% 0.019% 1.29% (0.348%) 0.024% 0.0048% 0.32% (0.0864%)

More information

2 1 7 - TALK ABOUT 21 μ TALK ABOUT 21 Ag As Se 2. 2. 2. Ag As Se 1 2 3 4 5 6 7 8 9 1 1 2 3 4 5 6 7 8 9 1 1 2 3 4 5 6 7 8 9 1 Sb Ga Te 2. Sb 2. Ga 2. Te 1 2 3 4 5 6 7 8 9 1 1 2 3 4 5 6 7 8 9 1 1 2 3 4

More information

xxxxEN.qxd

xxxxEN.qxd Ultron ES-VM : HPLC HPLC 28,000, 1-120Å 5-µm Ultron ES-VM [1-] Ultron ES-VM HPLC ph pi 3.8 4.3 Ultron ES-VM ph pi ph pka = 4.4 ph 3.0 6.0 pka = 4.0 9.2 k' 1 αph 1 Ibuprofen H3 C CHCH 2 CH CH H 3 C Chlorpheniramine

More information

エピトープタグ抗体製品リスト PM020 Anti-DDDDK-tag pab Polyclonal Rabbit Ig (aff.) WB, IP, IC 100 ml 15,000 PM020-7 Anti-DDDDK-tag pab HRP-DirecT Polyclonal Rabbit I

エピトープタグ抗体製品リスト PM020 Anti-DDDDK-tag pab Polyclonal Rabbit Ig (aff.) WB, IP, IC 100 ml 15,000 PM020-7 Anti-DDDDK-tag pab HRP-DirecT Polyclonal Rabbit I (kda) 150 100 DDDDK-tagged protein 75 50 37 IgG Heavy chain 25 20 IgG Light chain Sample: N-terminal DDDDK-tagged β-gal protein transfectant μ μ μ http://ruo.mbl.co.jp/ エピトープタグ抗体製品リスト PM020 Anti-DDDDK-tag

More information

A A

A A 3 A B C A A 2 5 1 62 A 1 1 2 63 3 1 A proven invasive fungal diseases 1 2 3 BAL 24 : Fusarium spp. 4 2 : Candida Trichosporon B probable invasive fungal diseases Cpossible invasive fungal diseases 5 1

More information

- 1 - 2 ç 21,464 5.1% 7,743 112 11,260 2,349 36.1% 0.5% 52.5% 10.9% 1,039 0.2% 0 1 84 954 0.0% 0.1% 8.1% 91.8% 2,829 0.7% 1,274 1,035 496 24 45.0% 36.6% 17.5% 0.8% 24,886 5.9% 9,661 717 6,350 8,203 38.8%

More information

2.7.6 MJR a MRI CT b 2 Beecham r-afs mg/ mg/ Gn-RH 742

2.7.6 MJR a MRI CT b 2 Beecham r-afs mg/ mg/ Gn-RH 742 MJR-35 34 1 1 a MRICT b 2Beecham r-afs 3 4 20 4 mg/ 20 40 5 6 2 1 2 3 44 mg/ 5 6 7 8 4 Gn-RH 742 9 10 11 12 1 20 60 1 1MJR-351 mg/ 0.25 2 Lot. No. 2MJR-352 mg/ 1 1 Lot. No. 3MJR-354 mg/ 1 2 Lot. No. 2

More information

分散分析・2次元正規分布

分散分析・2次元正規分布 2 II L10(2016-06-30 Thu) : Time-stamp: 2016-06-30 Thu 13:55 JST hig F 2.. http://hig3.net ( ) L10 2 II(2016) 1 / 24 F 2 F L09-Q1 Quiz :F 1 α = 0.05, 2 F 3 H 0, : σ 2 1 /σ2 2 = 1., H 1, σ 2 1 /σ2 2 1. 4

More information

HotStarTaq Plus PCRプロトコールとトラブルシューティング( /2008)

HotStarTaq Plus PCRプロトコールとトラブルシューティング( /2008) February 2008 HotStarTaq Plus PCR HotStarTaq Plus DNA Polymerase HotStarTaq Plus Master Mix Kit PCR HotStarTaq Plus DNA Polymerase PCR 2 HotStarTaq Plus DNA Polymerase Q-Solution PCR 6 HotStarTaq Plus

More information

12 ( 1) 70 1 ( 2) 2 4 4 45 38 3 3 3 6000 500 500-50 +50

12 ( 1) 70 1 ( 2) 2 4 4 45 38 3 3 3 6000 500 500-50 +50 9:11-38 2009 11 2008 12 26 3 46 12 ( 1) 70 1 ( 2) 2 4 4 45 38 3 3 3 6000 500 500-50 +50 13 38 5 19 5 19 Archaea/Eucarya 9 11 12 300 300 12 31 7 6 3 14 6 ( 8) 1973 1977 16S ribosomal RNA 2 90 80 8 ( 9)

More information